Francis Collins, director of the National Institutes of Health, wrote a blog post about the new study by scientists at the Harvard Stem Cell Institute who have discovered a hormone that might slow or stop the progression of diabetes. Douglas Melton, the Xander University Professor of Stem Cell and Regenerative Biology and co-director of the Harvard Stem Cell Institute and his postdoctoral fellow, Peng Yi, led the research.
